Association between MMP-12-82A/G polymorphism and cancer risk: a meta-analysis
- PMID: 26550102
- PMCID: PMC4612787
Association between MMP-12-82A/G polymorphism and cancer risk: a meta-analysis
Abstract
Background: Numerous studies have focused on the association between MMP-12-82A>G polymorphism and cancer risk, but produced inconsistent results. Therefore, we performed a meta-analysis of case-control study to evaluate the association of MMP-12-82A>G polymorphism and cancer risk.
Methods: A systematic literature search was conducted among PubMed, Web of Science, Science Direct, China National Knowledge Infrastructure (CNKI) and Wangfang databases updated on May 1st, 2015. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to evaluate the strength of association between this polymorphism and cancer risk.
Results: A total of seventeen case-control studies with 7,450 cases and 7,348 controls were identified and analyzed. Overall, there was no statistically significant association between MMP-12-82A>G polymorphism and increased risk of cancer under all genetic models. Subgroup analysis by ethnicity observed that there is no strong relationship between MMP-12-82A>G polymorphism and cancer risk among Asian and European populations. Furthermore, stratified analysis based on the source of control revealed no statistically significant association between MMP-12-82A>G polymorphism and cancer risk either in hospital-based or population-based studies. However, when we stratified analysis based on cancer type, significant association was found in ovarian cancer, but not in other types of cancer.
Conclusion: This meta-analysis suggests that MMP-12-82A>G polymorphism is not significantly associated with overall cancer risk. However, MMP-12-82A>G polymorphism may increase the susceptibility to ovarian cancer.
Keywords: Matrix metalloproteinases-12; cancer risk; meta-analysis; polymorphism.
Figures



Similar articles
-
Genetic Association between Matrix Metalloproteinases Gene Polymorphisms and Risk of Prostate Cancer: A Meta-Analysis.Front Physiol. 2017 Dec 1;8:975. doi: 10.3389/fphys.2017.00975. eCollection 2017. Front Physiol. 2017. PMID: 29249982 Free PMC article.
-
Association between MMP-9 -1562 C/T polymorphism and susceptibility to digestive cancers: A meta-analysis.Gene. 2018 Oct 5;673:88-94. doi: 10.1016/j.gene.2018.06.025. Epub 2018 Jun 8. Gene. 2018. PMID: 29890308
-
Association between cytotoxic T-lymphocyte antigen-4 +49A/G polymorphism and colorectal cancer risk: a meta-analysis.Int J Clin Exp Med. 2015 Mar 15;8(3):3752-60. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26064271 Free PMC article.
-
Association of MMP-2-753C>T and MMP-9-1562C>T Polymorphisms with Chronic/Aggressive Periodontitis Risk: A Systematic Review and Meta-Analysis.Iran J Public Health. 2019 Jul;48(7):1227-1238. Iran J Public Health. 2019. PMID: 31497543 Free PMC article. Review.
-
Association of β2-adrenergic receptor gene polymorphisms (rs1042713, rs1042714, rs1042711) with asthma risk: a systematic review and updated meta-analysis.BMC Pulm Med. 2019 Nov 7;19(1):202. doi: 10.1186/s12890-019-0962-z. BMC Pulm Med. 2019. PMID: 31699066 Free PMC article.
Cited by
-
Matrix metalloproteinase-2 gene polymorphisms are associated with ischemic stroke in a Hainan population.Medicine (Baltimore). 2018 Sep;97(39):e12302. doi: 10.1097/MD.0000000000012302. Medicine (Baltimore). 2018. PMID: 30278505 Free PMC article.
-
Spotlight on Proteases: Roles in Ovarian Health and Disease.Cells. 2025 Jun 18;14(12):921. doi: 10.3390/cells14120921. Cells. 2025. PMID: 40558552 Free PMC article. Review.
-
The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke.Int J Mol Sci. 2016 Aug 12;17(8):1323. doi: 10.3390/ijms17081323. Int J Mol Sci. 2016. PMID: 27529234 Free PMC article. Review.
-
Association between matrix metalloproteinases polymorphisms and ovarian cancer risk: A meta-analysis and systematic review.PLoS One. 2017 Sep 28;12(9):e0185456. doi: 10.1371/journal.pone.0185456. eCollection 2017. PLoS One. 2017. PMID: 28957437 Free PMC article.
-
Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.BMC Oral Health. 2021 Apr 23;21(1):205. doi: 10.1186/s12903-021-01571-7. BMC Oral Health. 2021. PMID: 33892690 Free PMC article.
References
-
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. - PubMed
-
- He YQ, Zhu JH, Huang SY, Cui Z, He J, Jia WH. The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis. Tumour Biol. 2015;35:12509–17. - PubMed
-
- Ding Q, Fan B, Fan Z, Ding L, Li F, Tu W, Jin X, Shi Y, Wang J. Interleukin-10-819C>T polymorphism contributed to cancer risk: evidence from 29 studies. Cytokine. 2013;61:139–45. - PubMed
-
- Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491–4. - PubMed
Publication types
LinkOut - more resources
Full Text Sources